PhaseBio Pharmaceuticals Inc: SC 13D/A filed Nov 4, 2022

Form type

SC 13D/A

Filing date

Nov 4, 2022

Accession number

0001072613-22-000603

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)